Brighter light during brain surgery could extend lives of glioblastoma patients
NCT ID NCT04391062
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 16 times
Summary
This study tested a new approach for glioblastoma, an aggressive brain cancer. During surgery to remove the tumor, doctors used a special light therapy (photodynamic therapy) with increasing light doses to see if it was safe. The goal was to improve the standard treatment of surgery followed by chemotherapy and radiation. The study involved 14 patients and focused on finding the highest safe light dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Roger Salengro, CHU Lille
Lille, 59037, France
-
Hôpital Erasme, Clinique Universitaire de Bruxelles
Brussels, Belgium
Conditions
Explore the condition pages connected to this study.